We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
+26.93%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$105B
AUM Growth
+$9.87B
(+10%)
Cap. Flow
-$5.55B
Cap. Flow
% of AUM
-5.31%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
2,219
New
117
Increased
528
Reduced
975
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertiv
VRT
|
+$446M |
| 2 |
Cisco
CSCO
|
+$406M |
| 3 |
Snowflake
SNOW
|
+$271M |
| 4 |
Visa
V
|
+$220M |
| 5 |
APi Group
APG
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$893M |
| 2 |
Palo Alto Networks
PANW
|
+$583M |
| 3 |
Microsoft
MSFT
|
+$480M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$474M |
| 5 |
Marvell Technology
MRVL
|
+$474M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.26% |
| 2 | Industrials | 13.78% |
| 3 | Healthcare | 11.68% |
| 4 | Financials | 8.38% |
| 5 | Consumer Discretionary | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Martin Marietta Materials
MLM
$32.8B
| $47.4M | 0.05% |
82,136
+44,850
| +120% | +$26.6M |
|
352
TransDigm Group
TDG
$67.4B
| $47.1M | 0.05% |
35,329
-2,736
| -7% | -$3.36M |
|
353
Arrowhead Research
ARWR
$12.5B
| $46.7M | 0.04% |
573,419
-699,847
| -55% | -$51.7M |
|
354
3M
MMM
$93.8B
| $45.7M | 0.04% |
282,009
-12,784
| -4% | -$1.94M |
|
355
JFrog
FROG
$10.7B
| $45.5M | 0.04% |
500,343
+484,283
| +3,015% | +$31.5M |
|
356
Cigna
CI
$73.6B
| $45.4M | 0.04% |
164,817
+15,742
| +11% | +$4.45M |
|
357
Kymera Therapeutics
KYMR
$8.86B
| $45M | 0.04% |
395,540
-73,188
| -16% | -$6.29M |
|
358
Darling Ingredients
DAR
$10B
| $44.9M | 0.04% |
821,537
+121,263
| +17% | +$7.24M |
|
359
Emcor
EME
$36.1B
| $44.8M | 0.04% |
54,031
-1,417
| -3% | -$1.2M |
|
360
Royal Caribbean
RCL
$82.4B
| $44.7M | 0.04% |
140,766
+23,109
| +20% | +$6.46M |
|
361
DexCom
DXCM
$33.1B
| $44.5M | 0.04% |
661,238
-95,090
| -13% | -$6.34M |
|
362
Mercado Libre
MELI
$92.4B
| $44.4M | 0.04% |
26,133
-122,714
| -82% | -$210M |
|
363
Hewlett Packard
HPE
$73.2B
| $44.3M | 0.04% |
982,129
+214,620
| +28% | +$7.75M |
|
364
Toll Brothers
TOL
$14B
| $44.1M | 0.04% |
267,602
+40,842
| +18% | +$5.81M |
|
365
Alkermes
ALKS
$8.25B
| $44M | 0.04% |
838,026
-104,158
| -11% | -$4.07M |
|
366
Valero Energy
VLO
$90.2B
| $43.6M | 0.04% |
167,218
-72,438
| -30% | -$17.8M |
|
367
GitLab
GTLB
$6.87B
| $43.5M | 0.04% |
1,426,021
+1,403,869
| +6,337% | +$35.6M |
|
368
Phillips 66
PSX
$85.1B
| $43M | 0.04% |
254,580
+13,507
| +6% | +$2.33M |
|
369
SLB Ltd
SLB
$78B
| $42.9M | 0.04% |
922,125
-75,077
| -8% | -$4.02M |
|
370
Cardinal Health
CAH
$55.6B
| $42.7M | 0.04% |
179,688
-15,669
| -8% | -$3.26M |
|
371
Hartford Financial Services
HIG
$38.8B
| $42.6M | 0.04% |
321,530
-29,319
| -8% | -$3.92M |
|
372
Bloom Energy
BE
$63.8B
| $42.4M | 0.04% |
140,197
-86,119
| -38% | -$22.1M |
|
373
Moderna
MRNA
$23.8B
| $42M | 0.04% |
602,512
-73,605
| -11% | -$3.81M |
|
374
ConocoPhillips
COP
$147B
| $41.9M | 0.04% |
403,337
-8,606
| -2% | -$1.02M |
|
375
Brookfield
BN
$108B
| $41.9M | 0.04% |
982,949
+129,219
| +15% | +$5.78M |
|
Similar funds
Pictet Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, Pictet Asset Management held 2,219 positions worth $105B, up 10% from $94.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Pictet Asset Management withdrew a net $5.55B in Q2 2026, closing 77 positions and reducing 975 holdings. Its most notable exit was Terns Pharmaceuticals, an estimated $87.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 35% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Pictet Asset Management opened a new position in Madison Air Solutions worth $173M.
- Pictet Asset Management's largest Q2 2026 buy was Madison Air Solutions: 4,434,713 shares worth $173M.
- Pictet Asset Management added most to Vertiv in Q2 2026, an estimated $446M increase.
- Pictet Asset Management's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $893M.
- Pictet Asset Management fully exited Terns Pharmaceuticals in Q2 2026, selling an estimated $87.3M.
- Pictet Asset Management's ten largest holdings make up 22% of its $105B portfolio in Q2 2026.
- Pictet Asset Management opened 117 new positions and closed 77 in Q2 2026.
- Pictet Asset Management's portfolio value rose 10% quarter-over-quarter to $105B.
Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.